Pokaż uproszczony rekord

Viruses-Basel

dc.contributor.authorBalaraman, Velmurugan
dc.contributor.authorIndran, Sabarish V.
dc.contributor.authorKim, In Joong
dc.contributor.authorTrujillo, Jessie D.
dc.contributor.authorMeekins, David A.
dc.contributor.authorShivanna, Vinay
dc.contributor.authorZajac, Michelle D.
dc.contributor.authorUrbaniak, Kinga
dc.contributor.authorMorozov, Igor
dc.contributor.authorSunwoo, Sun-Young
dc.contributor.authorFaburay, Bonto
dc.contributor.authorOsterrieder, Klaus
dc.contributor.authorGaudreault, Natasha N.
dc.contributor.authorWilson, William C.
dc.contributor.authorRicht, Juergen A.
dc.date.accessioned2024-06-03T08:55:45Z
dc.date.available2024-06-03T08:55:45Z
dc.date.issued2024
dc.identifierhttps://dspace.piwet.pulawy.pl/xmlui/handle/123456789/673
dc.identifier.issn1999-4915
dc.identifier.urihttps://www.mdpi.com/1999-4915/16/6/880
dc.identifier.uri
dc.description.abstractRift Valley fever (RVF) in ungulates and humans is caused by a mosquito-borne RVFphlebovirus (RVFV). Live attenuated vaccines are used in livestock (sheep and cattle) to control RVFin endemic regions during outbreaks. The ability of two or more different RVFV strains to reassortwhen co-infecting a host cell is a significant veterinary and public health concern due to the potentialemergence of newly reassorted viruses, since reassortment of RVFVs has been documented in natureand in experimental infection studies. Due to the very limited information regarding the frequencyand dynamics of RVFV reassortment, we evaluated the efficiency of RVFV reassortment in sheep,a natural host for this zoonotic pathogen. Co-infection experiments were performed, first in vitroin sheep-derived cells, and subsequently in vivo in sheep. Two RVFV co-infection groups wereevaluated: group I consisted of co-infection with two wild-type (WT) RVFV strains, Kenya 128B-15(Ken06) and Saudi Arabia SA01-1322 (SA01), while group II consisted of co-infection with the liveattenuated virus (LAV) vaccine strain MP-12 and a WT strain, Ken06. In the in vitro experiments,the virus supernatants were collected 24 h post-infection. In the in vivo experiments, clinical signswere monitored, and blood and tissues were collected at various time points up to nine days post-challenge for analyses. Cell culture supernatants and samples from sheep were processed, andplaque-isolated viruses were genotyped to determine reassortment frequency. Our results showthat RVFV reassortment is more efficient in co-infected sheep-derived cells compared to co-infectedsheep. In vitro, the reassortment frequencies reached 37.9% for the group I co-infected cells and25.4% for the group II co-infected cells. In contrast, we detected just 1.7% reassortant viruses fromgroup I sheep co-infected with the two WT strains, while no reassortants were detected from group IIsheep co-infected with the WT and LAV strains. The results indicate that RVFV reassortment occursat a lower frequency in vivo in sheep when compared to in vitro conditions in sheep-derived cells.Further studies are needed to better understand the implications of RVFV reassortment in relation tovirulence and transmission dynamics in the host and the vector. The knowledge learned from thesestudies on reassortment is important for understanding the dynamics of RVFV evolution.
dc.language.isoen
dc.publisherMDPI
dc.subjectRift Valley fever phlebovirus
dc.subjectbunyavirus
dc.subjectsheep
dc.subjectreassortment
dc.titleRift Valley Fever Phlebovirus Reassortment Study in Sheep
dcterms.bibliographicCitation2024 vol. 16 nr 880
dcterms.titleViruses-Basel
dc.identifier.doi10.3390/v16060880


Pliki tej pozycji

Thumbnail

Pozycja umieszczona jest w następujących kolekcjach

Pokaż uproszczony rekord